about
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammationNeuroimaging the epileptogenic processPost-traumatic epilepsy: current and emerging treatment optionsIssues related to development of antiepileptogenic therapies.Anti-epileptogenic clinical trial designs in epilepsy: issues and optionsSearching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategiesProspects for imaging-related biomarkers of human epileptogenesis: a critical reviewHippocampal neuro-networks and dendritic spine perturbations in epileptogenesis are attenuated by neuroprotectin d1.Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler's murine encephalomyelitis virus mouseRole of hormones and neurosteroids in epileptogenesis.Disease modification in epilepsy: from animal models to clinical applications.Exploring the latest avenues for antiepileptic drug discovery and development.Prevention of Epilepsy: Issues and Innovations.Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.New strategies for preventing epileptogenesis: perspective and overview.Low-frequency stimulation inhibits epileptogenesis by modulating the early network of the limbic system as evaluated in amygdala kindling model.Epilepsy after head injury in dogs: a natural model of posttraumatic epilepsy.
P2860
Q26823386-7153DDBE-10CA-45F9-9FCB-DEC6B24D3867Q26992310-873AC40D-3F03-4FED-8130-DF1E7832B115Q27004055-2E2C997A-B4B5-4706-9D9F-C3DC2AD269E5Q27016115-980C2631-4269-4A56-9863-C72274BDD6E9Q27027689-AE0E29AC-193A-491C-B6A2-784443AA4FF8Q30576762-0701B5BC-8176-404F-B2D3-58450DCAA414Q34049484-FA47DDC0-DFD4-4284-8B82-0930F5F97559Q35008940-9A69A24B-70C6-442F-A453-E3B7548893D6Q35531800-822F6417-DFA4-4271-B89F-4974ED64C756Q37057683-635267D0-279D-4E1E-BFC0-4FE617B15CBEQ38450069-C6E73DDD-DFE5-431C-A296-536FB3C1C1F7Q38754189-52699FB4-F425-45BD-B37F-39F2F7F60FBCQ38954567-F41008A3-633A-445B-9FBA-EDD3708DE036Q39126886-D23DAAF3-7D01-4A19-8DF6-124A375D7F4FQ41761673-66D7D6B5-9FBF-4BE6-A70A-08F136A1D117Q43995549-7BC97B43-B40C-4A02-9DAC-CB425807EE25Q48223148-83B81EBF-83BF-4E48-B182-CF65A16DE230
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human clinical trails in antiepileptogenesis.
@en
Human clinical trails in antiepileptogenesis.
@nl
type
label
Human clinical trails in antiepileptogenesis.
@en
Human clinical trails in antiepileptogenesis.
@nl
prefLabel
Human clinical trails in antiepileptogenesis.
@en
Human clinical trails in antiepileptogenesis.
@nl
P2093
P2860
P1433
P1476
Human clinical trails in antiepileptogenesis.
@en
P2093
John Pollard
Marc A Dichter
P2860
P304
P356
10.1016/J.NEULET.2011.03.010
P407
P577
2011-03-23T00:00:00Z